These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 10484286

  • 1. L-deprenyl inhibits tumor growth, reduces serum prolactin, and suppresses brain monoamine metabolism in rats with carcinogen-induced mammary tumors.
    ThyagaRajan S, Quadri SK.
    Endocrine; 1999 Jun; 10(3):225-32. PubMed ID: 10484286
    [Abstract] [Full Text] [Related]

  • 2. Deprenyl reinitiates estrous cycles, reduces serum prolactin, and decreases the incidence of mammary and pituitary tumors in old acyclic rats.
    Thyagarajan S, Meites J, Quadri SK.
    Endocrinology; 1995 Mar; 136(3):1103-10. PubMed ID: 7867565
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors.
    ThyagaRajan S, Felten SY, Felten DL.
    Cancer Lett; 1998 Jan 30; 123(2):177-83. PubMed ID: 9489486
    [Abstract] [Full Text] [Related]

  • 4. Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumors.
    ThyagaRajan S, Madden KS, Stevens SY, Felten DL.
    J Neuroimmunol; 2000 Sep 22; 109(2):95-104. PubMed ID: 10996211
    [Abstract] [Full Text] [Related]

  • 5. Region-specific alterations in the concentrations of catecholamines and indoleamines in the brains of young and old F344 rats after L-deprenyl treatment.
    ThyagaRajan S, Stevens SY, Felten DL.
    Brain Res Bull; 1999 Mar 15; 48(5):513-20. PubMed ID: 10372512
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of tumor growth by L-deprenyl involves neural-immune interactions in rats with spontaneously developing mammary tumors.
    Thyagarajan S, Madden KS, Stevens SY, Felten DL.
    Anticancer Res; 1999 Mar 15; 19(6B):5023-8. PubMed ID: 10697505
    [Abstract] [Full Text] [Related]

  • 7. Deprenyl stimulates the efflux of monoamines from the rat hypothalamus in vitro.
    MohanKumar PS, MohanKumar SM, Quadri SK.
    Brain Res Bull; 2001 Apr 15; 54(6):675-80. PubMed ID: 11403995
    [Abstract] [Full Text] [Related]

  • 8. L-Deprenyl stimulates the release of catecholamines in the rat medial basal hypothalamus in vivo.
    ThyagaRajan S, Quadri SK.
    Neurosci Lett; 1999 Jul 30; 270(2):79-82. PubMed ID: 10462102
    [Abstract] [Full Text] [Related]

  • 9. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 30; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 10. Changes in mediobasal hypothalamic dopamine and indoleamine metabolism after superior cervical ganglionectomy of rats.
    Esquifino AI, Arce A, Muñoz RM, Villanúa MA, Cardinali DP.
    J Neural Transm (Vienna); 1996 Oct 30; 103(3):287-98. PubMed ID: 8739840
    [Abstract] [Full Text] [Related]

  • 11. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 30; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 12. Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.
    Gupta M, Wiener HL.
    Neurochem Res; 1995 Apr 30; 20(4):385-9. PubMed ID: 7544444
    [Abstract] [Full Text] [Related]

  • 13. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T, Lamensdorf I, Finberg JP.
    Br J Pharmacol; 2000 Aug 30; 130(8):1992-8. PubMed ID: 10952692
    [Abstract] [Full Text] [Related]

  • 14. The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts.
    Fogel WA, Andrzejewski W, Sasiak K, Maslinski C.
    Inflamm Res; 2000 Apr 30; 49 Suppl 1():S45-6. PubMed ID: 10864416
    [No Abstract] [Full Text] [Related]

  • 15. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
    Kumagae Y, Matsui Y, Iwata N.
    Jpn J Pharmacol; 1991 Jan 30; 55(1):121-8. PubMed ID: 1904113
    [Abstract] [Full Text] [Related]

  • 16. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P, Youdim MB.
    J Neurochem; 1986 May 30; 46(5):1359-65. PubMed ID: 2420928
    [Abstract] [Full Text] [Related]

  • 17. Deprenyl reduces serum prolactin concentrations in rats.
    MohanKumar PS, Meites J, Quadri SK.
    Life Sci; 1994 May 30; 54(13):841-5. PubMed ID: 8139373
    [Abstract] [Full Text] [Related]

  • 18. In vitro effects on monoamine uptake and release by the reversible monoamine oxidase-B inhibitors lazabemide and N-(2-aminoethyl)-p-chlorobenzamide: a comparison with L-deprenyl.
    Bondiolotti GP, Galva MD, Villa F, Sciaba L, Picotti GB.
    Biochem Pharmacol; 1995 Jun 29; 50(1):97-102. PubMed ID: 7605351
    [Abstract] [Full Text] [Related]

  • 19. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul 29; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain.
    Paterson IA, Davis BA, Durden DA, Juorio AV, Yu PH, Ivy G, Milgram W, Mendonca A, Wu P, Boulton AA.
    Neurochem Res; 1995 Dec 29; 20(12):1503-10. PubMed ID: 8789614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.